News
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...
Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.
The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...
2d
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type ...
In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
SAN FRANCISCO -- Menopause hormone therapy (MHT) was tied to a weight-loss boost in postmenopausal women taking a weight loss ...
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...
Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results